|
US1160099A
(en)
|
1911-10-04 |
1915-11-09 |
Mark Cangen |
Heel-breast-scouring machine.
|
|
US2418499A
(en)
|
1944-06-20 |
1947-04-08 |
Du Pont |
2-alkoxymethylmercapto-thiazoles and thiazolines and a process for preparing the same
|
|
DE1070760B
(de)
|
1955-11-19 |
1959-12-10 |
Badische Anilin- S- Soda-Fabrik Aktiengesellschaft, Ludwigshafen / Rhein |
Verfahren zur Herstellung von Azofarbstoffen
|
|
GB849541A
(en)
|
1956-02-23 |
1960-09-28 |
Rohm & Haas |
Preparation of unsaturated cyclic urea derivatives
|
|
DE1273533B
(de)
|
1962-09-08 |
1968-07-25 |
Hoechst Ag |
Verfahren zur Herstellung von N-(ª‡-Alkoxy-alkyl)-carbonsaeureamiden
|
|
NL128370C
(https=)
|
1964-08-28 |
|
|
|
|
US3452034A
(en)
|
1967-03-09 |
1969-06-24 |
American Cyanamid Co |
Substituted 2-(1,3,4-thiadiazol-2-yl)-4(5)-nitroimidazoles
|
|
US3573308A
(en)
|
1969-04-03 |
1971-03-30 |
Hoffmann La Roche |
3-lower alkoxy methyl-3,4-dihydro-4-hydroxy-4-aryl quinazolin-2(1h) ones and related compounds
|
|
US3957808A
(en)
|
1969-09-03 |
1976-05-18 |
Rohm And Haas Company |
3-alkoxyisothiazoles
|
|
US3798219A
(en)
|
1971-10-18 |
1974-03-19 |
Warner Lambert Co |
3-(methylsulfinyl)cinnolinones and their derivatives
|
|
US3998815A
(en)
|
1974-06-24 |
1976-12-21 |
Interx Research Corporation |
1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts
|
|
US4727151A
(en)
|
1974-06-24 |
1988-02-23 |
Interx Research Corporation |
Labile quaternary ammonium salts as prodrugs
|
|
US4204065A
(en)
|
1975-09-22 |
1980-05-20 |
Interx Research Corporation |
Soft quaternary surface active agents and method of using same
|
|
JPS5331676A
(en)
|
1976-09-06 |
1978-03-25 |
Mitsui Toatsu Chem Inc |
Uracil derivatives and their preparation
|
|
US4260769A
(en)
|
1977-04-22 |
1981-04-07 |
Interx Research Corporation |
5,5-Diphenylhydantoins
|
|
JPS54130587A
(en)
|
1978-03-30 |
1979-10-09 |
Otsuka Pharmaceut Co Ltd |
Carbostyryl derivative
|
|
DE2960178D1
(en)
|
1978-06-06 |
1981-04-09 |
Hoechst Ag |
New substituted phenylpiperazine derivatives, pharmaceutical compositions containing them and process for their preparation
|
|
FR2454760A1
(fr)
|
1979-04-27 |
1980-11-21 |
Sumitomo Chemical Co |
Procede de production de derives de 3,5-dioxo-1,2,4-triazine, nouveaux produits ainsi obtenus et leur utilisation comme herbicides
|
|
JPS568318A
(en)
|
1979-06-28 |
1981-01-28 |
Janssen Pharmaceutica Nv |
Non oral long acting composition of haloperidol and bromperidol derivative
|
|
DE3149010A1
(de)
|
1981-12-10 |
1983-07-07 |
A. Nattermann & Cie GmbH, 5000 Köln |
(+)-2-(1-(2,6-dichlorphenoxy)-ethyl)-1,3- diazacyclopent-2-en, dessen herstellung und seine verwendung in pharamazeutischen praeparaten
|
|
US4428935A
(en)
|
1982-05-24 |
1984-01-31 |
Pfizer Inc. |
Penicillanic acid dioxide prodrug
|
|
US4448906A
(en)
|
1982-06-16 |
1984-05-15 |
Nuodex Inc. |
Surface-coating compositions
|
|
IT1212743B
(it)
|
1983-05-17 |
1989-11-30 |
Dompe Farmaceutici Spa |
Sali quaternari di derivati di benzo[ 1,4 ]diazepinonici,pirido [1,4]benzodiazepinonici,prido [1,5]benzodiazepinonici e loro atti vita' farmacologica
|
|
JPS602331A
(ja)
|
1983-06-20 |
1985-01-08 |
Yoshino Kogyosho Co Ltd |
飽和ポリエステル樹脂製壜の成形方法
|
|
US4760057A
(en)
|
1983-06-23 |
1988-07-26 |
Merck & Co., Inc. |
(Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs
|
|
DK302883D0
(da)
|
1983-06-30 |
1983-06-30 |
Hans Bundgaard |
Allopurinol prodrugs
|
|
US4500708A
(en)
|
1984-04-23 |
1985-02-19 |
G. D. Serle & Co. |
Benzothiazine derivatives
|
|
DE3544134A1
(de)
|
1984-12-15 |
1986-06-19 |
Mitsubishi Chemical Industries Ltd., Tokio/Tokyo |
Verfahren zur herstellung von n-((alpha)-alkoxyethyl) pyrrolidon
|
|
JPS61171467A
(ja)
|
1985-01-23 |
1986-08-02 |
Mitsubishi Chem Ind Ltd |
Ｎ−（α−アルコキシエチル）ピロリドンの製造方法
|
|
AR240698A1
(es)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
DK173350B1
(da)
|
1985-02-26 |
2000-08-07 |
Sankyo Co |
Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
|
|
GB8513754D0
(en)
|
1985-05-31 |
1985-07-03 |
Jones T R |
Anti-cancer quinazoline derivatives
|
|
FR2587029B1
(fr)
|
1985-09-11 |
1987-10-30 |
Synthelabo |
Derives de benzimidazole, leur preparation et leur application en therapeutique
|
|
DK588486A
(da)
|
1985-12-09 |
1987-06-10 |
Otsuka Pharma Co Ltd |
Anvendelse af en forbindelse til behandling af hypoxi
|
|
GB8607683D0
(en)
|
1986-03-27 |
1986-04-30 |
Ici Plc |
Anti-tumor agents
|
|
MX173362B
(es)
|
1987-03-02 |
1994-02-23 |
Pfizer |
Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
|
|
JPS63284165A
(ja)
|
1987-05-14 |
1988-11-21 |
Sankyo Co Ltd |
５−フルオロウラシル誘導体
|
|
US4925860A
(en)
|
1987-08-05 |
1990-05-15 |
E. I. Du Pont De Nemours And Company |
Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester
|
|
US4831031A
(en)
|
1988-01-22 |
1989-05-16 |
Pfizer Inc. |
Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
|
|
GB8809978D0
(en)
|
1988-04-27 |
1988-06-02 |
Ici Plc |
Anti-tumour agents
|
|
JP2608788B2
(ja)
|
1988-10-31 |
1997-05-14 |
大塚製薬 株式会社 |
精神分裂病治療剤
|
|
US5006528A
(en)
|
1988-10-31 |
1991-04-09 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
|
DK24089D0
(da)
|
1989-01-20 |
1989-01-20 |
Hans Bundgaard |
Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups
|
|
WO1991000863A1
(en)
|
1989-07-07 |
1991-01-24 |
Pfizer Inc. |
Heteroaryl piperazine antipsychotic agents
|
|
US5350747A
(en)
|
1989-07-07 |
1994-09-27 |
Pfizer Inc |
Heteroaryl piperazine antipsychotic agents
|
|
GB9007569D0
(en)
|
1990-04-04 |
1990-05-30 |
Nycomed As |
Carbo-nucleoside derivatives
|
|
US5229382A
(en)
|
1990-04-25 |
1993-07-20 |
Lilly Industries Limited |
2-methyl-thieno-benzodiazepine
|
|
JP2800953B2
(ja)
|
1990-07-06 |
1998-09-21 |
住友製薬株式会社 |
新規なイミド誘導体
|
|
DK238190D0
(da)
|
1990-10-03 |
1990-10-03 |
Lundbeck & Co As H |
Depotderivater
|
|
US5206386A
(en)
|
1991-03-20 |
1993-04-27 |
Isp Investments Inc. |
Controlled release N-substituted pyrrolidone esters and process for the use thereof
|
|
MX9201991A
(es)
|
1991-05-02 |
1992-11-01 |
Jonh Wyeth & Brother Limited |
Derivados de piperazina y procedimiento para su preparacion.
|
|
TW226016B
(https=)
|
1991-12-30 |
1994-07-01 |
Sterling Winthrop Inc |
|
|
JPH05194517A
(ja)
|
1992-01-16 |
1993-08-03 |
Tanabe Seiyaku Co Ltd |
６−メルカプトプリン誘導体及びその製法
|
|
US5462934A
(en)
|
1992-03-09 |
1995-10-31 |
Takeda Chemical Industries |
Condensed heterocyclic ketone derivatives and their use
|
|
WO1993025197A1
(en)
|
1992-06-12 |
1993-12-23 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
|
ATE185564T1
(de)
|
1992-08-31 |
1999-10-15 |
Sankyo Co |
Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
|
|
JP3526575B2
(ja)
|
1993-03-08 |
2004-05-17 |
エーザイ株式会社 |
ホスホン酸誘導体
|
|
TW376319B
(en)
|
1993-04-28 |
1999-12-11 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
|
|
DE4439493A1
(de)
|
1994-10-25 |
1996-05-02 |
Schering Ag |
Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
RO119545B1
(ro)
|
1995-02-28 |
2004-12-30 |
H. Lundbeck A/S |
Derivaţi de 4-aminotetrahidrobenzizoxazol ca inhibitori ai absorbţiei gaba
|
|
JP3571795B2
(ja)
|
1995-04-18 |
2004-09-29 |
株式会社日本触媒 |
Ｎ−（１−アルキルオキシアルキル）カルバメート類の気相分子内脱アルコール反応用触媒およびｎ−ビニルカルバメート類の製造方法
|
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
WO1997035586A1
(en)
|
1996-03-25 |
1997-10-02 |
Eli Lilly And Company |
Method for treating pain
|
|
DE69736704T2
(de)
|
1996-03-29 |
2007-09-13 |
Duphar International Research B.V. |
Piperazin- und piperidin- derivate
|
|
ATE210670T1
(de)
|
1996-04-30 |
2001-12-15 |
Warner Lambert Co |
Verbessertes verfahren zur herstellung von diestern aus 2,5-dioxo-4,4-diphenyl-imidazolidin- 1-ylmethyl phosphorsäureester
|
|
DE19619819A1
(de)
|
1996-05-16 |
1997-11-20 |
Boehringer Mannheim Gmbh |
Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltenden Arzneimittel
|
|
RU2186562C2
(ru)
|
1996-08-22 |
2002-08-10 |
Ресеч Трайангл Фармасьютикалс Лтд. |
Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления
|
|
RU2205831C2
(ru)
|
1997-04-25 |
2003-06-10 |
Янссен Фармацевтика Н.В. |
Хиназолиноны, ингибирующие фарнезилтрансферазу
|
|
WO1998056422A1
(en)
|
1997-06-13 |
1998-12-17 |
The University Of Kansas |
Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof
|
|
KR100537713B1
(ko)
|
1997-09-30 |
2005-12-20 |
일라이 릴리 앤드 캄파니 |
2-메틸-티에노-벤조디아제핀 제제
|
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
|
US6180095B1
(en)
|
1997-12-17 |
2001-01-30 |
Enzon, Inc. |
Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
|
|
KR20010033811A
(ko)
|
1997-12-31 |
2001-04-25 |
토마스 안 빅토리아 |
2차 및 3차 아민을 함유하는 약제의 물에 용해가능한프로드럭 및 그것의 제조방법
|
|
US6150366A
(en)
|
1998-06-15 |
2000-11-21 |
Pfizer Inc. |
Ziprasidone formulations
|
|
WO2000015612A1
(en)
|
1998-08-26 |
2000-03-23 |
Aventis Pharma Limited |
Aza-bicycles which modulate the inhibition of cell adhesion
|
|
FR2783519B1
(fr)
|
1998-09-23 |
2003-01-24 |
Sod Conseils Rech Applic |
Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
|
|
GB9904275D0
(en)
|
1999-02-24 |
1999-04-21 |
Cancer Res Campaign Tech |
Anti-cancer compounds
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6509334B1
(en)
|
1999-05-04 |
2003-01-21 |
American Home Products Corporation |
Cyclocarbamate derivatives as progesterone receptor modulators
|
|
US6444668B1
(en)
|
1999-05-04 |
2002-09-03 |
Wyeth |
Combination regimens using progesterone receptor modulators
|
|
US20060034937A1
(en)
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
IL150929A0
(en)
|
2000-01-28 |
2003-06-24 |
Rohm & Haas |
Pharmaceutical compounds comprising a pharmaceutically active moiety and a moiety comprising a substituent that enhances its properties
|
|
CA2311734C
(en)
|
2000-04-12 |
2011-03-08 |
Bristol-Myers Squibb Company |
Flash-melt oral dosage formulation
|
|
MY128450A
(en)
|
2000-05-24 |
2007-02-28 |
Upjohn Co |
1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
|
|
US6656505B2
(en)
|
2000-07-21 |
2003-12-02 |
Alpharma Uspd Inc. |
Method for forming an aqueous flocculated suspension
|
|
US20030049320A1
(en)
|
2000-12-18 |
2003-03-13 |
Wockhardt Limited |
Novel in-situ forming controlled release microcarrier delivery system
|
|
US7053092B2
(en)
|
2001-01-29 |
2006-05-30 |
Otsuka Pharmaceutical Co., Ltd. |
5-HT1a receptor subtype agonist
|
|
BR0207865A
(pt)
|
2001-02-14 |
2004-03-23 |
Warner Lambert Co |
Benzotiadiazinas inibidores de metaloproteinases de matriz
|
|
US20060293217A1
(en)
|
2001-03-19 |
2006-12-28 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained release
|
|
WO2002074247A2
(en)
|
2001-03-19 |
2002-09-26 |
Praecis Pharmaceuticals Incorporated |
Pharmaceutical formulations for sustained release
|
|
JP2005503351A
(ja)
|
2001-04-03 |
2005-02-03 |
アリックス セラピューティクス |
経皮適用のための超短時間作用性オピオイド
|
|
MY129350A
(en)
|
2001-04-25 |
2007-03-30 |
Bristol Myers Squibb Co |
Aripiprazole oral solution
|
|
WO2002100861A1
(en)
|
2001-06-13 |
2002-12-19 |
Akzo Nobel N.V. |
1-(3-phenyloxypropyl)piperidine derivatives
|
|
AR033485A1
(es)
|
2001-09-25 |
2003-12-26 |
Otsuka Pharma Co Ltd |
Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
|
|
ES2316777T3
(es)
|
2002-02-15 |
2009-04-16 |
Glaxo Group Limited |
Moduladores de receptores vainilloides.
|
|
HRP20040853A2
(en)
|
2002-03-20 |
2004-12-31 |
Bristol Myers Squibb Co |
Phosphate prodrugs of fluorooxindoles
|
|
EP1493448A4
(en)
|
2002-04-05 |
2007-12-05 |
Sankyo Co |
MEDICAL COMPOSITION WITH ACAT HEMMER AND AGENT TO IMPROVE INSULIN RESISTANCE
|
|
EP1558252B1
(en)
|
2002-08-02 |
2007-10-10 |
Merck & Co., Inc. |
Substituted furo [2,3-b]pyridine derivatives
|
|
CA2495864C
(en)
|
2002-08-20 |
2011-09-27 |
Bristol-Myers Squibb Company |
Aripiprazole complex formulation and method
|
|
HRP20050248A2
(en)
|
2002-09-17 |
2005-10-31 |
Warner-Lambert Company Llc |
Heterocyclic substituted piperazines for the treatment of schizophrenia
|
|
US7148211B2
(en)
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
|
AU2003271064B2
(en)
|
2002-09-27 |
2010-06-17 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel adenine compound and use thereof
|
|
KR100755625B1
(ko)
|
2002-10-24 |
2007-09-04 |
화이자 프로덕츠 인크. |
신경이완 활성을 갖는 5-(2-(4-(1,2벤즈이소티아졸-3-일)-1-피페라지닐)에틸)-6-클로로-1,3-디히드로-2ｈ-인돌-2-온의 아실 유도체
|
|
US20040156931A1
(en)
|
2002-12-18 |
2004-08-12 |
Algorx |
Administration of capsaicinoids
|
|
PT1605956E
(pt)
|
2002-12-18 |
2016-03-09 |
Centrexion Therapeutics Corp |
Administração de capsaicinóides para o tratamento da osteoartrite
|
|
DE10303669A1
(de)
|
2003-01-28 |
2004-07-29 |
Hans-Knöll-Institut für Naturstoff-Forschung e.V. |
Tetraalkylammoniumsalze vom Kohlensäureestertyp, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
|
KR20070087266A
(ko)
|
2003-04-03 |
2007-08-28 |
세마포르 파머슈티컬즈, 아이엔씨. |
피아이-3 키나아제 억제제 프로드러그
|
|
CN102166359A
(zh)
|
2003-05-23 |
2011-08-31 |
大塚制药株式会社 |
用于治疗情感障碍的喹诺酮衍生物和情绪稳定剂
|
|
SI1651265T1
(sl)
|
2003-07-24 |
2008-10-31 |
Merial Ltd |
Formulacije cepiva, ki obsegajo emulzijo olje v vodi
|
|
US6987111B2
(en)
|
2003-08-06 |
2006-01-17 |
Alkermes Controlled Therapeutics, Ii |
Aripiprazole, olanzapine and haloperidol pamoate salts
|
|
US20050032811A1
(en)
|
2003-08-06 |
2005-02-10 |
Josiah Brown |
Methods for administering aripiprazole
|
|
US7160888B2
(en)
|
2003-08-22 |
2007-01-09 |
Warner Lambert Company Llc |
[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
|
|
CN100559182C
(zh)
|
2003-08-29 |
2009-11-11 |
株式会社东芝 |
显色试剂、浓度测定试剂盒、浓度测定方法和在该方法中使用的传感器芯片
|
|
ATE411797T2
(de)
|
2003-10-23 |
2008-11-15 |
Otsuka Pharma Co Ltd |
Sterile injizierbare aripiprazol-formulierung mit kontrollierter freisetzung und verfahren
|
|
JP2007517014A
(ja)
|
2003-12-31 |
2007-06-28 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
Ｎ−置換ピペリジン及びピペラジン誘導体
|
|
AR047530A1
(es)
|
2004-02-04 |
2006-01-25 |
Novartis Ag |
Formas de sal de 4-(4-metilpiperazin-1-ilmetil)-n-(4-metil-3-(4-piridin-3-il)pirimidin-2-ilamino)fenil)-benzamida
|
|
WO2005079807A1
(en)
|
2004-02-13 |
2005-09-01 |
Pfizer Products Inc. |
Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
|
|
US7169803B2
(en)
|
2004-03-15 |
2007-01-30 |
Bristol-Myers Squibb Company |
N-substituted prodrugs of fluorooxindoles
|
|
KR101085979B1
(ko)
|
2004-03-23 |
2011-11-22 |
닛산 가가쿠 고교 가부시키 가이샤 |
항부정맥제로 사용되는 삼환계 벤조피란 화합물
|
|
US7119214B2
(en)
|
2004-04-13 |
2006-10-10 |
Cephalon France |
Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
|
|
GB2413795A
(en)
|
2004-05-05 |
2005-11-09 |
Cipla Ltd |
Process for the preparation of rosiglitazone
|
|
WO2005120577A2
(en)
|
2004-06-09 |
2005-12-22 |
Ramot At Tel Aviv University Ltd. |
Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity
|
|
US7405216B2
(en)
|
2004-08-18 |
2008-07-29 |
Solvay Pharmaceuticals, B.V. |
Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
|
|
WO2006037090A2
(en)
|
2004-09-28 |
2006-04-06 |
Purdue Research Foundation |
Drug-phosphate conjugates as prodrugs
|
|
AU2005307797B2
(en)
|
2004-11-16 |
2011-06-02 |
Alkermes Pharma Ireland Limited |
Injectable nanoparticulate olanzapine formulations
|
|
WO2006082588A2
(en)
|
2005-02-07 |
2006-08-10 |
Pharmalight Inc. |
Method and device for ophthalmic administration of active pharmaceutical ingredients
|
|
GB0502573D0
(en)
|
2005-02-08 |
2005-03-16 |
Topotarget As |
Therapeutic compounds
|
|
WO2006090273A2
(en)
|
2005-02-22 |
2006-08-31 |
Warner-Lambert Company Llc |
[1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia
|
|
JP4866349B2
(ja)
|
2005-06-13 |
2012-02-01 |
大日本住友製薬株式会社 |
可溶化型製剤
|
|
CA2622758A1
(en)
|
2005-09-15 |
2007-03-29 |
Elan Pharma International, Limited |
Nanoparticulate aripiprazole formulations
|
|
EP1777222A1
(en)
|
2005-09-22 |
2007-04-25 |
Galantos Pharma GmbH |
Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
|
|
AU2006310283A1
(en)
|
2005-10-31 |
2007-05-10 |
Pfizer Products Inc. |
Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-but oxy]-3,4-dihydro-1H-(1,8)naphthyridin-2-one
|
|
US20070185069A1
(en)
|
2005-11-14 |
2007-08-09 |
Plum Stacy M |
Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
|
|
MY149143A
(en)
|
2006-01-18 |
2013-07-15 |
Amgen Inc |
Thiazole compounds as protien kinase b (pkb) inhibitors
|
|
TW200804359A
(en)
|
2006-01-19 |
2008-01-16 |
Speedel Experimenta Ag |
Substituted 4-phenylpiperidines
|
|
CN101395158A
(zh)
|
2006-03-07 |
2009-03-25 |
百时美施贵宝公司 |
可作为激酶抑制剂的吡咯并三嗪苯胺前体药物化合物
|
|
AU2007291234A1
(en)
|
2006-08-31 |
2008-03-06 |
Solvay Pharmaceuticals B.V. |
Titration schedule for bifeprunox for treating schizophrenia and kits for use therein
|
|
US20090068290A1
(en)
|
2006-08-31 |
2009-03-12 |
Michel Bourin |
Bifeprunox doses for treating schizophrenia
|
|
US20080085888A1
(en)
|
2006-09-15 |
2008-04-10 |
Breining Scott R |
Therapeutic Combinations
|
|
US20090291134A1
(en)
|
2006-11-21 |
2009-11-26 |
Jina Pharmaceuticals, Inc. |
Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
|
|
CN101678120A
(zh)
|
2006-12-05 |
2010-03-24 |
纽罗吉斯克斯公司 |
前药及其制备和使用方法
|
|
US20100098641A1
(en)
|
2006-12-13 |
2010-04-22 |
William Baker |
Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and Bronchoconstriction
|
|
TWI325694B
(en)
|
2006-12-15 |
2010-06-01 |
Ind Tech Res Inst |
All digital delay locked loop
|
|
EP2120909A2
(en)
|
2006-12-15 |
2009-11-25 |
Ordway Research Institute |
Treatments of therapy-resistant diseases comprising drug combinations
|
|
EP1961412A1
(en)
|
2006-12-27 |
2008-08-27 |
LEK Pharmaceuticals D.D. |
Self-microemulsifying drug delivery systems
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
CA2681506C
(en)
|
2007-03-19 |
2016-05-24 |
Perry Peters |
Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
|
|
WO2008124030A1
(en)
|
2007-04-04 |
2008-10-16 |
Merck & Co., Inc. |
Therapeutic agents
|
|
EP2162135A4
(en)
|
2007-05-21 |
2012-02-22 |
Reviva Pharmaceuticals Inc |
COMPOSITIONS, SYNTHESIS AND METHOD FOR THE APPLICATION OF ATTAINED CHINOLINONE-BASED ANTIPSYCHOTICS
|
|
US20090012045A1
(en)
|
2007-06-26 |
2009-01-08 |
Rigel Pharmaceuticals, Inc. |
Methods of Treating Cell Proliferative Disorders
|
|
US20100292316A1
(en)
|
2007-07-18 |
2010-11-18 |
Research Development Foundation |
Improved therapeutic methods and compositions comprising chroman ring compounds
|
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
EP2217564A1
(en)
|
2007-09-07 |
2010-08-18 |
XenoPort, Inc. |
Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
|
|
US8076334B2
(en)
|
2007-09-20 |
2011-12-13 |
Hoffmann-La Roche Inc. |
Prodrugs of thyroid hormone analogs
|
|
WO2009052467A1
(en)
|
2007-10-19 |
2009-04-23 |
Board Of Regents Of The University Of Texas System |
Methods of identifying pi-3-kinase inhibitor resistance
|
|
CL2008003305A1
(es)
|
2007-11-06 |
2009-06-05 |
M/S Panacea Biotec Ltd |
Composicion inyectable que comprende un agente activo seleccionado de un grupo definido; al menos un polimero bioerosionable, al menos un solvente no toxico y opcionalmente uno o mas excipientes; proceso de preparacion; uso para tratar enfermedades mentales o cancer.
|
|
BRPI0821408A2
(pt)
|
2007-12-19 |
2015-06-16 |
Janssen Pharmaceutica Nv |
Regime de dosagem associado a ésteres de paliperidona injetáveis de longa ação
|
|
CA2709784A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US9161943B2
(en)
|
2007-12-31 |
2015-10-20 |
Industrial Technology Research Institute |
Sustained release composition and manufacturing method thereof
|
|
US8138169B2
(en)
|
2008-04-11 |
2012-03-20 |
Comgenrx, Inc. |
Combination therapy for bipolar disorder
|
|
US20110003823A1
(en)
|
2008-08-01 |
2011-01-06 |
Alpha Synergy Development, Inc. |
Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
|
|
WO2010027921A1
(en)
|
2008-09-03 |
2010-03-11 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical formulations comprising the same
|
|
US8017515B2
(en)
|
2008-12-10 |
2011-09-13 |
Stats Chippac, Ltd. |
Semiconductor device and method of forming compliant polymer layer between UBM and conformal dielectric layer/RDL for stress relief
|
|
PL2565193T3
(pl)
|
2009-01-23 |
2014-07-31 |
Rigel Pharmaceuticals Inc |
Kompozycje i sposoby hamowania szlaku JAK
|
|
EP2389169A1
(en)
|
2009-01-26 |
2011-11-30 |
Egalet A/S |
Controlled release formulations with continuous efficacy
|
|
TW201105667A
(en)
|
2009-05-08 |
2011-02-16 |
Cytopathfinder Inc |
Dihydronaphthyridinyl and related compounds for use in treating ophthalmological disorders
|
|
US8190546B2
(en)
|
2009-05-15 |
2012-05-29 |
At&T Intellectual Property I, L.P. |
Dependency between sources in truth discovery
|
|
LT2445502T
(lt)
|
2009-06-25 |
2017-09-25 |
Alkermes Pharma Ireland Limited |
Heterocikliniai junginiai, skirti neurologinių ir fiziologinių susirgimų gydymui
|
|
CA2937222C
(en)
|
2009-06-25 |
2019-06-04 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds
|
|
UY32730A
(es)
|
2009-06-26 |
2011-01-31 |
Novartis Ag |
Inhibidores de cyp17
|
|
MX2012005083A
(es)
|
2009-10-30 |
2012-09-28 |
Janssen Pharmaceutica Nv |
Regimen de dosificacion asociado con esteres de paliperidona inyetables de accion prolongada.
|
|
US20110166156A1
(en)
|
2010-01-07 |
2011-07-07 |
Alkermes, Inc. |
Prodrugs for the Treatment of Schizophrenia and Bipolar Disease
|
|
WO2011084848A2
(en)
|
2010-01-07 |
2011-07-14 |
Alkermes, Inc. |
Prodrugs of heteraromatic compounds
|
|
WO2011084849A1
(en)
|
2010-01-07 |
2011-07-14 |
Alkermes, Inc. |
Diaryldiazepine prodrugs for the treatment of neurological and psychological disorders
|
|
WO2011084846A1
(en)
|
2010-01-07 |
2011-07-14 |
Alkermes, Inc. |
Quaternary ammonium salt prodrugs
|
|
US20110166194A1
(en)
|
2010-01-07 |
2011-07-07 |
Alkermes, Inc. |
Asenapine Prodrugs
|
|
EP2538202A4
(en)
|
2010-02-16 |
2018-03-21 |
Hamamatsu Photonics K.K. |
Gas concentration calculation device and gas concentration measurement module
|
|
CA2797708C
(en)
|
2010-05-04 |
2016-08-16 |
Alkermes Pharma Ireland Limited |
Process for synthesizing oxidized lactam compounds
|
|
CN102260290A
(zh)
|
2010-05-25 |
2011-11-30 |
苏州波锐生物医药科技有限公司 |
喹喏啉酮类化合物及其在制备精神病药物中的用途
|
|
US8691836B2
(en)
|
2010-06-18 |
2014-04-08 |
Altos Therapeutics, LLC |
D2 antagonists, methods of synthesis and methods of use
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
AU2011270701B2
(en)
|
2010-06-24 |
2015-05-14 |
Alkermes Pharma Ireland Limited |
Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
JP6013364B2
(ja)
|
2010-12-23 |
2016-10-25 |
アルカーメス ファーマ アイルランド リミテッド |
マルチプルａｐｉローディングプロドラッグ
|
|
BR112013023847B1
(pt)
|
2011-03-18 |
2021-02-23 |
Alkermes Pharma Ireland Limited |
composições farmacêuticas compreendendo ésteres de sorbitano e uso das mesmas
|
|
NZ722096A
(en)
|
2011-12-15 |
2016-11-25 |
Alkermes Pharma Ireland Ltd |
Prodrugs of secondary amine compounds
|
|
AU2013235523B9
(en)
|
2012-03-19 |
2018-01-04 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising glycerol esters
|
|
CA2867121C
(en)
|
2012-03-19 |
2021-05-25 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising fatty acid esters
|
|
AU2013235526B2
(en)
|
2012-03-19 |
2017-11-30 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions comprising benzyl alcohol
|
|
JP6654042B2
(ja)
|
2012-09-19 |
2020-02-26 |
アルカームス ファーマ アイルランド リミテッド |
貯蔵安定性が改善された医薬組成物
|
|
US8669281B1
(en)
|
2013-03-14 |
2014-03-11 |
Alkermes Pharma Ireland Limited |
Prodrugs of fumarates and their use in treating various diseases
|
|
BR112015022854A2
(pt)
|
2013-03-14 |
2017-07-18 |
Alkermes Pharma Ireland Ltd |
pró-farmacos de fumaratos e uso do mesmo no tratamento de várias doenças
|
|
US10525057B2
(en)
|
2013-09-24 |
2020-01-07 |
Otsuka Pharmaceutical Co., Ltd. |
Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
|
|
CN106132415A
(zh)
|
2014-03-20 |
2016-11-16 |
奥克梅斯制药爱尔兰有限公司 |
具有增加的注射速度的阿立哌唑制剂
|
|
US10016415B2
(en)
*
|
2014-08-18 |
2018-07-10 |
Alkermes Pharma Ireland Limited |
Aripiprazole prodrug compositions
|
|
ES2884849T3
(es)
*
|
2014-08-18 |
2021-12-13 |
Alkermes Pharma Ireland Ltd |
Composiciones de profármaco de aripiprazol
|
|
WO2016032950A1
(en)
|
2014-08-25 |
2016-03-03 |
Alkermes Pharma Ireland Limited |
Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia
|
|
EP3761983A1
(en)
*
|
2018-03-05 |
2021-01-13 |
Alkermes Pharma Ireland Limited |
Aripiprazole dosing strategy
|